ヘッジホッグ経路の阻害
Aleksandar Sekulic1, Daniel Von Hoff2
1Department of Dermatology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Cell
|February 27, 2016
まとめ
(Hh) 信号伝達経路は,基礎細胞癌 (BCC) で極めて重要です. ビジモデジブとソニデジブのような標的治療はスムートネッド (SMO) を阻害し,先進的なBCCに対して承認されています.
科学分野:
- 腫瘍学
- 分子生物学
- 皮膚科
背景:
- エジホッグ (Hh) 信号経路の異常な活性化は,基礎細胞癌 (BCC) の特徴である.
- この経路はBCCの発達と進行において重要な役割を果たします.
- Hh経路の異常を理解することは 効果的な治療法の開発の鍵です
研究 の 目的:
- 基礎細胞癌 (BCC) のシグナル伝達経路 (Hh) の役割を検討する.
- Smoothened (SMO) 阻害剤の作用メカニズムについて説明する.
- 承認されたSMO阻害剤のBCC治療における臨床応用を強調する.
主な方法:
- BCCにおけるヘッジホッグ信号に関する研究の文献レビュー.
- SMO阻害剤の臨床試験データの分析
- BCC療法に対する規制当局の承認のレビュー
主要な成果:
- ヘッジホッグ (Hh) 信号経路は,基礎細胞癌 (BCC) で頻繁に過剰に活性化されます.
- Vismodegibとsonidegibは,Hh経路の重要な構成要素であるSMOを阻害する標的療法です.
- 局所的に進行したBCC (laBCC) の治療には,ヴィスマデギブとソネデギブの両方が承認されています.
結論:
- エジホッグ (Hh) 経路のスムージド (SMO) コンポーネントの標的型阻害は,基礎細胞癌 (BCC) 治療の効果的な戦略です.
- 局所発症および転移したBCCの管理において,ヴィスマデジブとソネデジブは重要な進歩を示しています.
- Hh経路阻害剤に関する継続的な研究は,BCC患者のさらなる治療選択肢を提供することができる.
さらに関連する動画
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
20.8K
04:06Efficient and Cost Effective Electroporation Method to Study Primary Cilium-Dependent Signaling Pathways in the Granule Cell Precursor
Published on: November 30, 2021
2.8K
関連する概念動画
Hedgehog Signaling Pathway
1.8K
1.8K
Hedgehog Signaling Pathway
10.4K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.4K
Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
IP3/DAG Signaling Pathway
15.8K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.8K
Notch Signaling Pathway
6.8K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Notch Signaling Pathway
6.5K
6.5K
